171 related articles for article (PubMed ID: 15322525)
21. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
Sauvé S; Tremblay L; Lavigne P
J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
[TBL] [Abstract][Full Text] [Related]
22. Site-directed mutagenesis supports a three-dimensional model of the runt domain.
Levanon D; Eisenstein M; Groner Y
J Mol Biol; 1998 Apr; 277(3):509-12. PubMed ID: 9533875
[TBL] [Abstract][Full Text] [Related]
23. Allosteric inhibition of the protein-protein interaction between the leukemia-associated proteins Runx1 and CBFbeta.
Gorczynski MJ; Grembecka J; Zhou Y; Kong Y; Roudaia L; Douvas MG; Newman M; Bielnicka I; Baber G; Corpora T; Shi J; Sridharan M; Lilien R; Donald BR; Speck NA; Brown ML; Bushweller JH
Chem Biol; 2007 Oct; 14(10):1186-97. PubMed ID: 17961830
[TBL] [Abstract][Full Text] [Related]
24. Chloride binding by the AML1/Runx1 transcription factor studied by NMR.
Wolf-Watz M; Bäckström S; Grundström T; Sauer U; Härd T
FEBS Lett; 2001 Jan; 488(1-2):81-4. PubMed ID: 11163800
[TBL] [Abstract][Full Text] [Related]
25. The intrinsically unstructured domain of PC4 modulates the activity of the structured core through inter- and intramolecular interactions.
Jonker HR; Wechselberger RW; Boelens R; Kaptein R; Folkers GE
Biochemistry; 2006 Apr; 45(15):5067-81. PubMed ID: 16605275
[TBL] [Abstract][Full Text] [Related]
26. DNA recognition by the RUNX1 transcription factor is mediated by an allosteric transition in the RUNT domain and by DNA bending.
Bartfeld D; Shimon L; Couture GC; Rabinovich D; Frolow F; Levanon D; Groner Y; Shakked Z
Structure; 2002 Oct; 10(10):1395-407. PubMed ID: 12377125
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the 2.0 A crystal structure of the protein-DNA complex of the human PDEF Ets domain bound to the prostate specific antigen regulatory site.
Wang Y; Feng L; Said M; Balderman S; Fayazi Z; Liu Y; Ghosh D; Gulick AM
Biochemistry; 2005 May; 44(19):7095-106. PubMed ID: 15882048
[TBL] [Abstract][Full Text] [Related]
28. RUN-CBFbeta interaction in C. elegans: computational prediction and experimental verification.
Suad O; Eyal E; Blumenzweig I; Kessler N; Levanon D; Groner Y; Shakked Z
J Biomol Struct Dyn; 2007 Feb; 24(4):343-58. PubMed ID: 17206850
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic potential of the RUNX gene family: 'overview'.
Ito Y
Oncogene; 2004 May; 23(24):4198-208. PubMed ID: 15156173
[TBL] [Abstract][Full Text] [Related]
30. Two-state allosteric behavior in a single-domain signaling protein.
Volkman BF; Lipson D; Wemmer DE; Kern D
Science; 2001 Mar; 291(5512):2429-33. PubMed ID: 11264542
[TBL] [Abstract][Full Text] [Related]
31. Crystallization and preliminary X-ray analyses of quaternary, ternary and binary protein-DNA complexes with involvement of AML1/Runx-1/CBFalpha Runt domain, CBFbeta and the C/EBPbeta bZip region.
Tahirov TH; Inoue-Bungo T; Sasaki M; Shiina M; Kimura K; Sato K; Kumasaka T; Yamamoto M; Kamiya N; Ogata K
Acta Crystallogr D Biol Crystallogr; 2001 Jun; 57(Pt 6):850-3. PubMed ID: 11375505
[TBL] [Abstract][Full Text] [Related]
32. Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells.
Wichmann C; Chen L; Heinrich M; Baus D; Pfitzner E; Zörnig M; Ottmann OG; Grez M
Cancer Res; 2007 Mar; 67(5):2280-9. PubMed ID: 17332359
[TBL] [Abstract][Full Text] [Related]
33. Molecular insights into PEBP2/CBF beta-SMMHC associated acute leukemia revealed from the structure of PEBP2/CBF beta.
Goger M; Gupta V; Kim WY; Shigesada K; Ito Y; Werner MH
Nat Struct Biol; 1999 Jul; 6(7):620-3. PubMed ID: 10404215
[TBL] [Abstract][Full Text] [Related]
34. Energetic contribution of residues in the Runx1 Runt domain to DNA binding.
Li Z; Yan J; Matheny CJ; Corpora T; Bravo J; Warren AJ; Bushweller JH; Speck NA
J Biol Chem; 2003 Aug; 278(35):33088-96. PubMed ID: 12807882
[TBL] [Abstract][Full Text] [Related]
35. Filamin A-bound PEBP2beta/CBFbeta is retained in the cytoplasm and prevented from functioning as a partner of the Runx1 transcription factor.
Yoshida N; Ogata T; Tanabe K; Li S; Nakazato M; Kohu K; Takafuta T; Shapiro S; Ohta Y; Satake M; Watanabe T
Mol Cell Biol; 2005 Feb; 25(3):1003-12. PubMed ID: 15657428
[TBL] [Abstract][Full Text] [Related]
36. Altered affinity of CBF beta-SMMHC for Runx1 explains its role in leukemogenesis.
Lukasik SM; Zhang L; Corpora T; Tomanicek S; Li Y; Kundu M; Hartman K; Liu PP; Laue TM; Biltonen RL; Speck NA; Bushweller JH
Nat Struct Biol; 2002 Sep; 9(9):674-9. PubMed ID: 12172539
[TBL] [Abstract][Full Text] [Related]
37. Core binding factor in the early avian embryo: cloning of Cbfbeta and combinatorial expression patterns with Runx1.
Bollerot K; Romero S; Dunon D; Jaffredo T
Gene Expr Patterns; 2005 Dec; 6(1):29-39. PubMed ID: 16033710
[TBL] [Abstract][Full Text] [Related]
38. The Ig fold of the core binding factor alpha Runt domain is a member of a family of structurally and functionally related Ig-fold DNA-binding domains.
Berardi MJ; Sun C; Zehr M; Abildgaard F; Peng J; Speck NA; Bushweller JH
Structure; 1999 Oct; 7(10):1247-56. PubMed ID: 10545320
[TBL] [Abstract][Full Text] [Related]
39. C-terminal domain of insulin-like growth factor (IGF) binding protein 6: conformational exchange and its correlation with IGF-II binding.
Yao S; Headey SJ; Keizer DW; Bach LA; Norton RS
Biochemistry; 2004 Sep; 43(35):11187-95. PubMed ID: 15366928
[TBL] [Abstract][Full Text] [Related]
40. Runt domains take the lead in hematopoiesis and osteogenesis.
Werner MH; Shigesada K; Ito Y
Nat Med; 1999 Dec; 5(12):1356-7. PubMed ID: 10581073
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
